Failure to treat keratoderma in Papillon-Lefevre syndrome using photodynamic therapy [12]

European Journal of Dermatology

Volumn 17, Issue 5, 2007, Pages 456-457

  Fernández Guarino, Montse ^a   Harto, Antonio ^a   Jaén, Pedro ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE I; LEVULINIC ACID; METILAMINLEVULENIC ACID; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG TOLERABILITY; HUMAN; KERATODERMA; KERATOSIS PALMOPLANTARIS; LETTER; MALE; PHOTODYNAMIC THERAPY; PHYSICAL EXAMINATION; RED LIGHT; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; HUMANS; LEVULINIC ACIDS; MALE; MIDDLE AGED; PAPILLON-LEFEVRE DISEASE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN; TREATMENT FAILURE;

EID: 34548735977     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Ullbro C, Crossner CG, Nederfors T, Alfadley A, Thestrup-Pedersen K. Dermatologic and oral findings in a cohort of 47 patients with Papillon-Lefevre syndrome. J Am Acad Dermatol 2003; 48: 345-51.
2. Lee MR, Wong LC, Fischer GO. Papillon-Lefevre syndrome treated with acitretin. Australas J Dermatol 2005; 46: 199-201.
3. Ohlerth S, Laluhova D, Buchholz J, Roos M, Walt H, Kaser-Hotz B. Changes in vascularity and blood volume as a result of photodynamic therapy can be assessed with power Doppler ultrasonography. Lasers Surg Med 2006; 38: 229-34.
4. Zane C, Venturini M, Sala R, Calzavara-Pinton P. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed 2006; 22: 254-8.
5. Kim JY, Kang HY, Lee ES, Kim YC. Topical 5-aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasis. J Dermatol 2007; 34: 37-40.
6. Ibbotson SH. Topical 5-aminolaevulinic acid pamic therapy for the treatment of skin conditions other than non melanoma skin cancer. Br J Dermatol 2002; 146: 178-188.